You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A cost-effective bioreactor to advance functional tissue engineering of cartilage
SBC: Apex Biomedical Company, LLC Topic: NIAMSDESCRIPTION (provided by applicant): Osteoarthritis (OA) is the leading cause of chronic disability in the United States. A clinical goal in the treatment and prevention of OA is to develop replacement cartilage using tissue engineering (TE) technologies. Although TE cartilage presently lacks the mechanical stability of native cartilage, studies have demonstrated that mechanical stability can be e ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
A dual histone deacetylase and glycogen synthase kinase 3 beta inhibitor for treating pancreatic adenocarcinoma
SBC: Avenzoar Pharmaceuticals, Inc. Topic: 102ABSTRACT Pancreatic cancer is a disease with no effective treatmentIt s low five year survival rateestimated at betweenandranks it the fourth highest of cancer related of death in the U Sdespite being the twelfth most common type of cancerEach year in the U Sthere are nearlynew cases and more thandeaths caused by the diseaseBypancreatic cancer is expected to be the second most common cancer relate ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Advanced Li/CFx Primary Batteries with Non-Flammable Electrolytes
SBC: CFX BATTERY, INC. Topic: T601NASA seeks to develop high specific energy primary batteries that are safe and capable of performing under a wide temperature range, for manned space missions. To meet this goal, CFX Battery Inc. proposes to develop, characterize, and establish technological feasibility of a new Li/SF-CFx based high capacity lithium primary battery that offers higher rate capability and enhanced safety than conven ...
STTR Phase I 2010 National Aeronautics and Space Administration -
Advanced Morphing Moulage for Medical Training (AMM-MT)
SBC: VCOM3D INC Topic: DHA17A002For this Phase I SBIR proposal, Vcom3D proposes to design advanced medical moulage that accurately simulates the progression of an injury or pathology by morphing through a series of clinical states to enable learners to confirm the progression of the wound and to determine whether iatrogenic errors or pathologies occurred duing treatment. The physical morphing moulage may be applied to medical m ...
STTR Phase I 2017 Department of DefenseDefense Health Agency -
Advanced Structural Health Monitoring System for Comprehensive Real-Time Vehicle Characterization
SBC: AMERICAN GNC CORPORATION Topic: T1In providing an innovative solution to improving information technologies and health management systems, AGNC is proposing a significant technological achievement with the Advanced Structural Health Monitoring System for Comprehensive Real-Time Vehicle Characterization. During in-flight conditions, this system is able to not only provide the status of information such as regarding the flight envel ...
STTR Phase I 2010 National Aeronautics and Space Administration -
Advanced Unsteady Turbulent Combustion Simulation Capability for Space Propulsion Systems
SBC: STREAMLINE NUMERICS, INC. Topic: T901The innovation proposed here is a high performance, high fidelity simulation capability to enable accurate, fast and robust simulation of unsteady turbulent, reacting flows involving cryogenic propellants (such as LOX/LH2 and LOX/LCH4). The key features of this proposed capability are: (a) Hybrid RANS-LES (HRLES) methodology, and (b) flamelet modeling for turbulent combustion incorporated in a pr ...
STTR Phase I 2010 National Aeronautics and Space Administration -
Advancing clemizole for hepatitis C: towards a pre-IND package
SBC: EIGER GROUP INTERNATIONAL, INC. Topic: NIAIDDESCRIPTION (provided by applicant): Over 150 million people worldwide are infected with the hepatitis C virus (HCV), which is an important cause of chronic liver disease. Current therapies are inadequate. Our long-term objective is to bring a new class of anti-HCV drugs to the clinic. We recently discovered and genetically validated a new target within the HCV non-structural protein NS4B, consist ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
AHTP-comet: development of an automated, high throughput comet assay system
SBC: ENGINEERING RESOURCES GROUP INC Topic: NIEHSPROJECT SUMMARY Genomic instabilityinduced by DNA damageand partly mitigated by DNA repair and antioxidantsplays a critical role in the pathogenesis of many major human diseasessuch as neurodegenerationcancer and cardiovascular diseasetogether with agingThere is a critical need for automated assays that can perform these assessmentsand bring them into greater routine usewhich will help advance our ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Air Vehicle Gust Response analysis for Conceptual Design
SBC: RESEARCH IN FLIGHT LLC Topic: T15Research in Flight (RIF) and Auburn University are offering the development of an advanced, robust tool and methodology that allows the simulation and modeling of gust and wake vortex encounters for Distributed Electric Propulsion (DEP) enabled Urban Air Mobility (UAM) vehicle concepts. DEP enabled UAM concepts offer the potential for large performance improvements by exploiting favorable synergie ...
STTR Phase I 2019 National Aeronautics and Space Administration -
Allergen???Fc-gamma1 proteins to treat food allergy
SBC: TUNITAS THERAPEUTICS, INC. Topic: NIAIDDESCRIPTION (provided by applicant): The goal of this proposal is to develop and commercialize a novel approach for allergen specific immunotherapy as treatment for severe food allergy. Food allergy affects about 3.5% of the US population and 6% to 8% of young children. It is clearly on the rise. Peanut allergy, which affects around 1% of the population, is among the most severe food allergies, r ...
STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health